The rice from California-based "pharming" firm Ventria Bioscience was designed to synthesize a human immune protein. The crop will soon be cultivated on 3,000 acres of land in Kansas, if the USDA finalizes its approval after a public comment period that ends March 30.
Reader comments: Robert Searfoss says,
Please note that NYTimes columnist Denise Caruso has a new book "Intervention" about the science that is used by agencies to look at and evaluate the risks of new transgenic experiments and products.
I've read it and it is one of the most important books Ive ever read. FYI I'm 61 years old and have done a LOT of quality reading.
Boing Boing editor/partner and tech culture journalist Xeni Jardin hosts and produces Boing Boing's in-flight TV channel on Virgin America airlines (#10 on the dial), and writes about living with breast cancer. Diagnosed in 2011. @xeni on Twitter. email: email@example.com.